日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Three-dimensional covariance-map imaging of molecular structure and dynamics on the ultrafast timescale

超快时间尺度上分子结构和动力学的三维协方差图成像

期刊:Communications Chemistry
影响因子:6.2
doi:10.1038/s42004-020-0320-3
Lee, Jason W L; Köckert, Hansjochen; Heathcote, David; Popat, Divya; Chapman, Richard T; Karras, Gabriel; Majchrzak, Paulina; Springate, Emma; Vallance, Claire
发表日期：2020
文献求助 收藏

Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data

利用汇总患者数据，对两项二线雷莫芦单抗III期研究（REGARD和RAINBOW）中胃癌患者的总生存期进行预后因素分析

期刊:Journal of Gastric Cancer
影响因子:3.8
doi:10.5230/jgc.2017.17.e16
Fuchs, Charles S; Muro, Kei; Tomasek, Jiri; Van Cutsem, Eric; Cho, Jae Yong; Oh, Sang-Cheul; Safran, Howard; Bodoky, György; Chau, Ian; Shimada, Yasuhiro; Al-Batran, Salah-Eddin; Passalacqua, Rodolfo; Ohtsu, Atsushi; Emig, Michael; Ferry, David; Chandrawansa, Kumari; Hsu, Yanzhi; Sashegyi, Andreas; Liepa, Astra M; Wilke, Hansjochen
胃癌
肿瘤
肿瘤免疫
发表日期：2017
文献求助 收藏

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program

舒尼替尼联合 FOLFIRI 方案与单纯 FOLFIRI 方案治疗化疗难治性晚期胃或下段食管腺癌患者：一项随机、安慰剂对照的 II 期 AIO 试验，并采用血清生物标志物方案

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-016-2736-9
Moehler, Markus; Gepfner-Tuma, Irina; Maderer, Annett; Thuss-Patience, Peter C; Ruessel, Joern; Hegewisch-Becker, Susanna; Wilke, Hansjochen; Al-Batran, Salah-Eddin; Rafiyan, Mohammad-Reza; Weißinger, Florian; Schmoll, Hans-Joachim; Kullmann, Frank; von Weikersthal, Ludwig Fischer; Siveke, Jens T; Weusmann, Jens; Kanzler, Stephan; Schimanski, Carl Christoph; Otte, Melanie; Schollenberger, Lukas; Koenig, Jochem; Galle, Peter R
肿瘤
肿瘤免疫
发表日期：2016
文献求助 收藏

Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer

诱导化疗的临床疗效可预测局部晚期食管癌患者多模式治疗中的局部控制和长期生存率。

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-004-0604-5
Stahl, Michael; Wilke, Hansjochen; Stuschke, Martin; Walz, Martin K; Fink, Ulrich; Molls, Michael; Siewert, J Rüdiger; Schroeder, Michael; Makoski, Hans-Bruno; Schmidt, Ulrich; Seeber, Siegfried; Vanhoefer, Udo
食管癌
肿瘤
肿瘤免疫
发表日期：2005
文献求助 收藏